← Back to episodes

Episode 76 ·

Eliminating Kickbacks in Recovery Act (EKRA): Comparison with the AKS

Send us Fan Mail The Eliminating Kickbacks in Recovery Act (EKRA) is a huge statute. In this episode, Captain Integrity Bob Wade discusses the similarities and differences between EKRA and the Anti-Kickback Statute (AKS). Hear why EKRA applies to private payers, there are broader applications under EKRA as opposed to the AKS, how EKRA applies generally to clinical laboratories, the origin of EKRA, and “liquid gold” in the recovery world. Learn more at CaptainIntegrity.com

  • Anti-Kickback Statute

Listen to the episode

Audio

Ready to play. Audio loads only after you press Play.

0:000:00

Prefer Buzzsprout? Listen on Buzzsprout.

Companion article

Eliminating Kickbacks in Recovery Act (EKRA): Comparison to the Anti-Kickback Statute

Episode Date: May 3, 2023

In this episode of Stark Integrity, Bob Wade (“Captain Integrity”) explores the Eliminating Kickbacks in Recovery Act (EKRA) and compares it to the Anti-Kickback Statute (AKS), highlighting key similarities, differences, and compliance challenges.

Bob breaks down why EKRA is an increasingly important statute for healthcare organizations and why it requires careful attention—even for those already familiar with AKS requirements.

What Is EKRA?

Bob begins by explaining that EKRA is a relatively newer federal statute that was enacted to combat fraud and abuse, particularly in the context of recovery homes, clinical treatment facilities, and laboratories.

He notes that EKRA:

  • Expands beyond traditional AKS frameworks
  • Applies to a broader range of payment arrangements
  • Covers both public and private payers

This broader scope makes EKRA especially important for organizations operating in areas such as laboratory services and substance use disorder treatment.

Key Differences from the Anti-Kickback Statute

A central theme of the episode is how EKRA differs from the Anti-Kickback Statute.

Bob explains that:

  • AKS primarily focuses on federal healthcare programs, while EKRA applies more broadly
  • EKRA can apply even when no federal healthcare dollars are involved
  • The statutory language and structure differ, creating unique compliance considerations

As a result, compliance with AKS alone does not necessarily ensure compliance with EKRA.

Broader Application and Increased Risk

Bob emphasizes that EKRA’s broader reach creates additional compliance risk.

He highlights that:

  • Arrangements involving private pay patients may still be subject to scrutiny
  • Compensation structures that may be permissible under AKS could raise issues under EKRA
  • Organizations must analyze arrangements under both frameworks

This overlap requires a more comprehensive and coordinated compliance approach.

Challenges in Interpretation

Another important point Bob raises is that EKRA can be more complex and less clearly defined than older statutes.

He explains that:

  • There is less historical guidance and case law compared to AKS
  • Interpretations may continue to evolve over time
  • Organizations must rely on careful analysis and professional judgment

This uncertainty increases the importance of proactive compliance review and monitoring.

Practical Implications for Healthcare Organizations

Bob outlines several practical implications of EKRA for healthcare organizations.

He explains that organizations should:

  • Review compensation arrangements for potential risks under both EKRA and AKS
  • Pay close attention to arrangements involving marketing, referrals, and incentives
  • Ensure that payment structures are defensible and compliant

Even familiar arrangements may require re-evaluation in light of EKRA.

Aligning Compliance Frameworks

A key takeaway from the episode is the importance of aligning compliance efforts across different regulatory frameworks.

Bob notes that:

  • EKRA and AKS must be considered together
  • Policies and procedures should reflect both statutes
  • Compliance teams should be educated on the distinctions and overlap

A siloed approach to compliance can leave organizations exposed to unnecessary risk.

Practical Takeaways

The key takeaway from this episode is that EKRA introduces new considerations that expand traditional fraud and abuse compliance analysis. Organizations should:

  • Understand how EKRA differs from the Anti-Kickback Statute
  • Evaluate arrangements under both EKRA and AKS frameworks
  • Reassess compensation and referral-related structures
  • Monitor evolving regulatory interpretations
  • Ensure compliance teams are informed and proactive

Final Thoughts

This episode highlights that EKRA is not simply an extension of existing laws—it is a distinct and broader regulatory framework that requires careful attention.

Bob’s discussion reinforces that organizations must stay informed and adaptable, ensuring that their compliance programs evolve alongside the regulatory landscape to effectively manage both AKS and EKRA risks.

Click here to listen to this Stark Integrity Podcast Episode:
https://podcasts.apple.com/us/podcast/eliminating-kickbacks-in-recovery-act-ekra-comparison/id1588939373?i=1000611528595&l=fr-FR